Objective: To assess the local and referred pain areas and pain characteristics evoked from temporalis muscle trigger points (TrPs) in chronic tension-type headache (CTTH).
T ension-type headache (TTH) is the most common type of headache with 1-year prevalence rates of 38.3% for the episodic form, and 2.2% for the chronic form chronic tension-type headache (CTTH). 1 Despite some advances, the pathogenesis of this primary headache is not clearly understood. Bendtsen 2 suggested a pain model for TTH where nociceptive inputs from tender muscles can lead to central sensitization seen in CTTH. Other authors have proposed that TTH is caused by referred pain evoked from several head, shoulder, and neck muscle.
3,4 Simons et al 4 described the referred pain patterns from different myofascial trigger points (TrPs) in head and neck muscles that have the potential to referred pain in the head region. Because TTH is characterized by bilateral, pressing, or tightening pain; pressure or bandlike tightness 5 ; and/or increased tenderness on palpation of neck and shoulder muscles, 6, 7 these pain features resemble the descriptions of referred pain originating in TrPs. strongly substantiated by histochemical findings at the TrP, because higher levels of nociceptive mediators have been recently found in active TrPs. 8 We postulated that TTH could be the manifestation of referred pain from TrPs located in the temporalis, sternocleidomastoid, upper trapezius, or suboccipital muscles. 3, 4, 9 Ferna´ndez-de-las-Pen˜as et al 10 found that CTTH was associated with active TrPs in the suboccipital muscles, and that those patients with active TrPs had greater headache intensity and frequency than those with latent TrPs. Furthermore, it was demonstrated that both referred pain and sensory characteristics elicited by manual exploration of TrPs in the upper trapezius muscle shared similar patterns as habitual headache pain, consistent with active TrPs, in CTTH patients. 11 Schmidt-Hansen et al 12 demonstrated that referred pain elicited by the infusion of hypertonic saline into the anterior or posterior temporalis muscles is perceived as head pain in healthy individuals. However, the relationship between TrP pain characteristics in the temporalis muscle and the headache has not been established in patients with CTTH.
The aims of the present study were: (1) to describe differences in localization, intensity, and quality of the local and referred pain elicited by TrPs in the temporalis muscle between CTTH patients and healthy individuals; (2) to describe whether the localization, intensity, and quality of the local and referred pain evoked by TrPs in the temporalis muscles mimic the pain pattern experienced by CTTH patients during headache attacks; (3) to assess the relationship between active or latent TrPs and several clinical variables concerning the intensity and the temporal profile of headache in CTTH patients; and, (4) to analyze if the decrease in pressure pain threshold (PPT) was related to the presence of TrPs in the temporalis muscle in both CTTH and healthy participants.
MATERIALS AND METHODS

Participants
A total of 30 CTTH patients, 9 men and 21 women, aged 18 to 65 years old (mean: 39 ± 16 y) and 30 healthy age and sex-matched patients, 9 men and 21 women, aged 19 to 65 (mean: 39 ± 12 y) without headache history participated in this study. Patients were recruited from a Neurology Department; whereas controls were recruited from the staff personal of the Hospital. All participants were right-handed. CTTH was diagnosed according to the International Headache Society (IHS). 5 To be included patients had to present those characteristics typical of tension-type headache: bilateral location, pressing, or tightening (nonpulsating) pain, mild-moderate intensity, and lack of aggravation during routine physical activity. None of the patients reported photophobia, phonophobia, vomiting, or evident nausea during headache. Patients had to experience headaches on at least 15 days per month for more than 3 months to be considered chronic. Patients with mixed headache were excluded. A headache diary was kept for 4 weeks to substantiate the diagnosis. 13 Medication-overuse headache as defined by the IHS 5 was ruled out in all cases. None of the patients received physical therapy and/or antidepressants by the time the study was completed. Patients were not allowed to take analgesics or muscle relaxants 24 hours before the examination. All patients were examined on days in which headache intensity was <4 points on a 10-cm horizontal visual analog scale (VAS). The research project was approved by the local human research committee. All participants signed an informed consent before their inclusion.
Myofascial Trigger Point Examination
Both temporalis muscles were examined for the presence of myofascial TrPs by an assessor who had more than 5 years' experience in TrPs diagnosis, and who was blinded to the patients diagnosis. TrP diagnosis was performed following the criteria described by Simons et al 4 and by Gerwin et al 14 :
(1) presence of a palpable taut band in a skeletal muscle; (2) presence of a hyperirritable tender spot within the taut band; (3) local twitch response elicited by the snapping palpation of the taut band; and (4) reproduction of referred pain in response to TrP compression. A TrP was considered active if the referred pain evoked by its compression reproduced the same patients head pain, whereas a TrP was considered latent if the evoked referred pain did not reproduce a usual or familiar pain.
4,14
Assessment of Pain Intensity, Quality, and Referred Pain Area
The intensity of the local pain, defined as pain located around the compression site, and referred pain, defined as pain located outside the local pain area evoked by TrP manual palpation, was scored on a 10-cm horizontal VAS (range: 0 = no pain, to 10 = maximum pain). 15 The quality of the evoked referred pain was assessed by the validated Spanish version of the McGill Pain Questionnaire (MPQ). 16, 17 Words from the MPQ chosen by at least 50% of patients were used to describe the referred pain quality. The patients was asked to draw the distribution of referred pain on an anatomic map after TrP palpation. The referred pain area was calculated with a digitizer (ACECAD D9000, Taiwan).
PPT Assessment
PPT is defined as the minimal amount of pressure where a sense of pressure first changes to pain. 18 A mechanical pressure algometer that consists of a round rubber disk (area 1 cm 2 ) attached to a pressure (force) gauge was used. The gauge displays values in kilograms, so the readings are expressed in kg/cm 2 . The range of the algometer is 0 to 10 with 0.1-kg divisions. Levoska 19 found an intraexaminer reliability ranging from 0.6 to 0.97, whereas the interexaminer reliability ranges from 0.4 to 0.98.
A standardized protocol was applied to calculate the PPT in the anterior part of the temporalis muscle. 20 The assessor applied continuous pressure at approximately a rate of 1 kg/cm 2 /s. Participants pressed the button when the pain threshold was reached, the reading displayed was stopped. Three consecutive pain threshold measurements at intervals of 30 seconds were obtained by the same assessor (intraexaminer reliability) and the mean was considered in the analysis. Sides were randomly assessed.
Patient or Control Assessment
All participants had 2 appointments within a 4-week period. At the first visit, assessor 1 gave a headache diary to patients. Each patient registered on the diary the daily headache intensity (VAS), headache duration (in hours per day), and the days with headache. Assessor 1 informed controls about physical therapy and headache, but did not give them a headache diary. Assessor 2, blinded to the participants condition, took the PPT measurement as described above in both patients and controls.
At the second visit 4 weeks later, assessor 2 examined randomly both temporalis muscles for the presence of TrPs. After TrP examination, patients and controls reported their pain, that is, intensity, quality, and referred pain location, measures. Finally, all patients returned the headache diary to the first assessor who calculated the following variables: (1) headache intensity, which was calculated from the mean of the VAS of the days with headache; (2) headache frequency (days per week); and (3) headache duration (hours per day).
Statistical Analysis
Data were analyzed with the SPSS statistical package (13.0 Version). A normal distribution of quantitative data was assessed by means of the Kolmogorov-Smirnov test. Because all quantitative data did not show a normal distribution, nonparametric tests were used. Differences in the number of either latent or active TrPs between both groups were assessed with the MannWhitney U test. The w 2 test was used to assess both the differences in occurrence of referred pain and the distribution of either latent or active TrPs within each side between both study groups. Referred pain areas were analyzed with 2-way (patient and controls, dominant and nondominant sides) analysis of variance. The MannWhitney U test was used to analyze the differences in both the clinical variables relating to headache (headache intensity, frequency, and/or duration) and PPT data in CTTH with either latent or active TrPs in either left or right sides. Within each study group, differences in PPT between right and left sides were assessed with the Wilcoxon signed rank test. Because no differences were found between right and left sides in both groups, data for comparison between groups were derived from the average of right and left values for each variable. Differences in PPT between both study groups were assessed with the Mann-Whitney U test. Finally, differences in both local pain and referred pain intensities between both sides were assessed with the Wilcoxon signed rank test. The statistical analysis was conducted at a 95% confidence level. A P value <0.05 was considered statistically significant.
RESULTS
Headache Diary
Headache history ranged from 3 to 36 years (mean duration: 10 ± 12 y). The mean headache period per day was 9.5 hours (minimum 6 h, maximum 12 h), and the mean intensity (VAS) per episode was 5.5 (minimum 3, maximum 9). CTTH patients were examined on days in which headache intensity was <4 on the VAS (mean: 3.1 ± 0.5). No correlation was found between headache history and the other clinical headache parameters.
Local and Referred Pain Intensity
All CTTH patients (n = 30) reported local pain during muscle palpation (VAS: 5.6 ± 1.2 right side, 5.3 ± 1.4 left side). Local pain was evoked in 14 controls (46%) in both right (VAS, mean: 0.8; SD: 0.7) and left (VAS, mean: 0.7; SD: 0.7) sides. CTTH patients reported significantly (P<0.001) higher local pain intensity than healthy controls in both temporalis muscles.
Within the CTTH group, referred pain intensity during muscle palpation was 4.7 (SD: 2) for the right temporalis muscle and 3.5 (SD: 2.8) for the left temporalis muscle. Within the control group, referred pain intensity was 0.3 (SD: 0.2) for the right temporalis muscle, and 0.4 (SD: 0.3) for left temporalis muscle. Referred pain intensity was significantly (P<0.001) greater in patients than in controls.
Referred pain, but not local pain, intensity was greater in both sides in CTTH patients presenting with bilateral TrPs than those patients with unilateral TrP (P<0.001). Table 1 details both local and referred pain intensities of both CTTH and control groups. 
Referred Pain Pattern in CTTH Patients
Within the CTTH group, referred pain from active and latent TrPs was obtained in 26 out of 30 (87%) right temporalis muscles, and 19 out of 30 (54%) left temporalis muscles. Because all patients were righthanded, the occurrence of referred pain was higher in the dominant than the nondominant temporalis muscle (P = 0.03). The reported referred pain (Fig. 1A) 
Referred Pain Pattern in Healthy Controls
Within the control group, referred pain from latent TrPs was obtained in 3 out of 30 (10%) in the right temporalis, and 5 out of 30 (17%) in the left temporalis muscle. The occurrence of referred pain was not significantly different in the dominant than the nondominant temporalis muscle (P>0.05). Referred pain area was confined only to the temple. The qualitative words mostly chosen were pressing (3/3 right side, 3/5 left side) and tightening (2/3 right side, 3/5 left side).
Comparison of the Referred Pain Area Between Patients and Controls
Two-way analysis of variance showed a significantly larger area of the local and referred pain in the patients than the controls (P<0.001), a significantly larger area in the right temporalis than the left temporalis (P<0.001) in patients (5.66 ± 0.36 vs. 2.96 ± 0.36 cm 2 ), but not in controls (0.67 ± 0.35 vs. 0.59 ± 0.35 cm 2 ) , and a statistically significant interaction (P<0.001) between participants (the patients or controls) and laterality (the right or left temporalis).
Myofascial Trigger Point Description
Seventeen out of 30 CTTH patients (57%) reported referred pain upon compression of the right temporalis muscle as their usual headache sensation, consistent with active TrPs. Twelve out of 30 CTTH patients (40%) reported referred pain evoked by compression of the left temporalis muscle as their usual head pain, that is, active TrPs. Further, 6 out of 30 patients (20%) had bilateral active trigger points associated with headache. Therefore, 23 out of 30 patients (77%) had active TrPs leading to their usual headache. The mean number of TrPs for each CTTH patient was 1.5 (SD: 0.5), of which 1 (SD: 0.6) were active, and 0.5 (SD: 0.6) were latent. On the other hand, none of the healthy participants recognized the evoked referred pain as a familiar pain, so they had latent, but not active, TrPs (mean: 0.3; SD: 0.4). TrP occurrence between the 2 groups was significantly different for active TrPs (P<0.001), but not for latent TrPs (P = 0.08).
Fifteen CTTH patients (50%) showed bilateral muscle TrPs, whereas the remaining 15 patients (50%) showed unilateral muscle TrP. Six CTTH patients showed active TrPs in the temporalis muscle bilaterally. On the other hand, none healthy participants showed bilateral latent TrPs, another 8 (27%) showed unilateral latent TrPs, and the remaining 22 (73%) controls showed no muscle TrP. Therefore, bilateral TrPs in the temporalis muscle were more conspicuous in CTTH patients than in controls (P<0.001).
Myofascial Trigger Point Activity and Headache Pain Characteristics in CTTH Patients
CTTH patients with active TrPs in the right temporalis muscle showed longer headache duration than those with latent TrPs (P = 0.004). Active TrPs in the left temporalis muscle were related to greater headache intensity and longer headache duration, but not headache frequency, than latent TrPs. Finally, headache parameters did not differ between CTTH patients (n = 15) with bilateral muscle TrPs and those with unilateral TrP (n = 15). Table 2 summarizes headache intensity, frequency, and duration data depending on TrP activity.
PPTs Data in Both Groups
The intraexaminer repeatability of PPT readings ranged from 0.9 to 0.92, suggesting high repeatability of the PPT data. No significant differences were found in PPT between right and left sides within both groups. CTTH patients showed significantly (P<0.001) lower PPT (1.1 ± 0.2 right side, 1.2 ± 0.3 left side) as compared with controls (2.5 ± 0.5 right side, 2.6 ± 0.4 left side).
Within the CTTH group, PPT on the right temporalis muscle was related to TrP activity on the ipsi-lateral muscle (P = 0.03): patients with active TrPs on the right side showed ipsilateral decreased PPT than those with latent TrPs. Conversely, cephalic PPT on the left side was not related to TrP activity on the left Table 3 shows PPT data depending on either active or latent TrPs in both study groups.
DISCUSSION
This study provides for the first time the evidence that the local and referred pain and pain characteristics elicited by manual examination of TrPs in the temporalis muscle share similar patterns as habitual headache pain in CTTH patients. The local and referred pain areas were larger in patients than in controls. Moreover, headache duration and intensity were greater in CTTH patients who had active TrPs compared to those with latent TrPs in the temporalis muscle. PPT values were lower in CTTH patients than in controls. Finally, both headache clinical parameters and cephalic PPT data did not differ between CTTH patients with bilateral muscle TrPs and those with unilateral TrP.
Stimulation of active TrPs in the temporalis muscle in patients reproduced usual headache pain symptoms in 57% (n = 17) and 40% (n = 12), respectively, in the right and left sides. Further, stimulation of active TrPs bilaterally in the temporalis muscle reproduced headache pain in 20% (n = 6) of the 30 CTTH patients. When TrPs in the temporalis muscle were explored by the assessor, many patients reported: ''Yes, this is exactly the pain that I usually feel.'' The pain area was referred to the temple and behind the eyes in patients, and confined to the temple in controls. The pain features elicited by the temporalis muscle are similar to those reported in CTTH patients in previous studies. 11, [21] [22] [23] There was close similarities between the referred pain pattern from temporalis muscle in our CTTH patients (Fig. 1A) and the experimentally induced in healthy participants (Fig. 1B) . 12 These results argue for the view that active TrPs in the temporalis muscle is contributing to CTTH and referred pain from TrPs may contribute directly to TTH perception.
Unilateral stimulation of the temporalis muscle evoke unilateral referred pain, bilateral stimulation of both muscles evoke symmetrically referred pain patterns, and referred pain intensity was greater in CTTH patients with bilateral TrPs than those with unilateral TrPs. Furthermore, bilateral TrPs in the temporalis muscle were more conspicuous in patients than in controls. Although Ferna´ndez-de-las-Pen˜as et al 11 found that CTTH patients with bilateral TrPs in the upper trapezius muscle reported higher levels of headache and longer headache duration than those with unilateral TrPs, these results have not been replicated in this study, because headache parameters did not differ between patients with bilateral muscle TrPs and those with unilateral TrP in the temporalis muscle.
It has been postulated that hyperalgesia in CTTH patients may be due to an increased sensitivity (hyperexcitability) in the central nervous system provoked by nociceptive stimuli from peripheral structures.
2 Central sensitization may be also involved in the generation of muscle referred pain. Different studies have found that the area of the referred pain correlated with the intensity of the muscle pain. 24, 25 Secondary hyperalgesia surrounding a painful area is related to central sensitization, which may account for muscle referred pain. In that way, muscle Values are expressed as means ( ± SDs). VAS indicates Visual Analog Scale (0 to 10 cm). referred pain may also correlate with the phenomena of secondary hyperalgesia and tenderness seen in TTH patients. 26 In addition, peripheral and central sensitization and decreased descending inhibition induced by longterm nociceptive stimuli from trigger points may also involve in referred pain to trigeminal region from active TrPs in the temporalis muscle. 27 Olesen 28 proposed that headache is due to an excess of nociceptive inputs from peripheral structures. According to his model, headache intensity is the sum of nociceptive inputs from cranial and extracranial tissues converging on trigeminal nucleus caudalis neurons. Animal 29 and human 30, 31 studies clearly show the convergence of cervical and trigeminal afferents (trigeminal nerve nucleus caudalis), constituting the anatomic basis for the referred headache pain from the TrPs. Further, Schmidt-Hansen et al 12 have recently demonstrated that the temporalis muscle elicited referred pain to both the trigeminal territory (anterior part of the muscle), and to the cervical innervated dermatome (posterior part of the muscle). Continuous or prolonged nociceptive afferent input resulting in temporal and spatial summation could lead to central sensitization postulated to occur in CTTH. It is possible that nociceptive inputs from head and neck muscle TrPs can produce a continuous afferent bombardment to the trigeminal nerve nucleus caudalis. Because higher levels of algogenic substances (ie, bradykinin, calcitonin gene-related peptide, substance P, tumor necrosis factor-a, interleukin-1b, serotonin, and norepinephrine) have been found in TrPs, 8 but not in tender points, 32 we can postulate that referred pain elicited by TrPs in the temporalis muscle can play an important role in the genesis of CTTH. However, the fundamental understanding of TrP anatomy and physiology is not completely understood.
Although the local and referred pain elicited by TrPs in the temporalis muscle reproduced the usual headache pain in several of our CTTH patients, head pain of certain patients may have other sources, for example, suboccipital muscles, 10 upper trapezius muscle, 11 malalignment of upper cervical vertebrae, 33 or superior oblique muscle. 34 It seems that several musculoskeletal disorders from the cranio-cervical region are contributing at the same time to headache pain perception in TTH. Our results underline the importance of inspection and inactivation of TrPs in the temporalis muscle in CTTH patients. Because an association between TrPs in the temporalis muscle and CTTH has been found in this study; a therapeutic approach based on TrP management should now be evaluated.
In conclusion, CTTH patients show signs of hypersensitivity (lower PPT and larger referred pain areas) of the central nervous system. In addition, the evoked local and referred pain by TrPs in the temporalis muscle and its sensory characteristics shared similar patterns as their habitual headache pain, consistent with active TrPs. The local and referred pain from active TrPs in the temporalis muscles constitutes one of the sources of CTTH. Further research is needed to define the pathogenic role of referred pain from the TrPs in other head and neck muscles in the genesis and/or maintenance of TTH.
